CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins

Standard

CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins. / Krebs, Christian; Adriouch, Sahil; Braasch, Fenja; Koestner, Wolfgang; Leiter, Edward H; Seman, Michel; Lund, Frances E; Oppenheimer, Norman; Haag, Friedrich; Koch-Nolte, Friedrich.

in: J IMMUNOL, Jahrgang 174, Nr. 6, 15.03.2005, S. 3298-305.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Krebs, C, Adriouch, S, Braasch, F, Koestner, W, Leiter, EH, Seman, M, Lund, FE, Oppenheimer, N, Haag, F & Koch-Nolte, F 2005, 'CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins', J IMMUNOL, Jg. 174, Nr. 6, S. 3298-305.

APA

Krebs, C., Adriouch, S., Braasch, F., Koestner, W., Leiter, E. H., Seman, M., Lund, F. E., Oppenheimer, N., Haag, F., & Koch-Nolte, F. (2005). CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins. J IMMUNOL, 174(6), 3298-305.

Vancouver

Krebs C, Adriouch S, Braasch F, Koestner W, Leiter EH, Seman M et al. CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins. J IMMUNOL. 2005 Mär 15;174(6):3298-305.

Bibtex

@article{4660879a4fee48a1b5ec3401f366a6bf,
title = "CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins",
abstract = "ADP-ribosyltransferase-2 (ART2), a GPI-anchored, toxin-related ADP-ribosylating ectoenzyme, is prominently expressed by murine T cells but not by B cells. Upon exposure of T cells to NAD, the substrate for ADP-ribosylation, ART2 catalyzes ADP-ribosylation of the P2X7 purinoceptor and other functionally important cell surface proteins. This in turn activates P2X7 and induces exposure of phosphatidylserine and shedding of CD62L. CD38, a potent ecto-NAD-glycohydrolase, is strongly expressed by most B cells but only weakly by T cells. Following incubation with NAD, CD38-deficient splenocytes exhibited lower NAD-glycohydrolase activity and stronger ADP-ribosylation of cell surface proteins than their wild-type counterparts. Depletion of CD38(high) cells from wild-type splenocytes resulted in stronger ADP-ribosylation on the remaining cells. Similarly, treatment of total splenocytes with the CD38 inhibitor nicotinamide 2'-deoxy-2'-fluoroarabinoside adenine dinucleotide increased the level of cell surface ADP-ribosylation. Furthermore, the majority of T cells isolated from CD38-deficient mice {"}spontaneously{"} exposed phosphatidylserine and lacked CD62L, most likely reflecting previous encounter with ecto-NAD. Our findings support the notion that ecto-NAD functions as a signaling molecule following its release from cells by lytic or nonlytic mechanisms. ART2 can sense and translate the local concentration of ecto-NAD into corresponding levels of ADP-ribosylated cell surface proteins, whereas CD38 controls the level of cell surface protein ADP-ribosylation by limiting the substrate availability for ART2.",
keywords = "ADP Ribose Transferases, ADP-ribosyl Cyclase, Adenosine Diphosphate Ribose, Animals, Antigens, CD, Antigens, CD38, Immunomagnetic Separation, In Vitro Techniques, L-Selectin, Membrane Glycoproteins, Membrane Proteins, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, NAD, Phosphatidylserines, T-Lymphocytes, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.",
author = "Christian Krebs and Sahil Adriouch and Fenja Braasch and Wolfgang Koestner and Leiter, {Edward H} and Michel Seman and Lund, {Frances E} and Norman Oppenheimer and Friedrich Haag and Friedrich Koch-Nolte",
year = "2005",
month = mar,
day = "15",
language = "English",
volume = "174",
pages = "3298--305",
journal = "J IMMUNOL",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

RIS

TY - JOUR

T1 - CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins

AU - Krebs, Christian

AU - Adriouch, Sahil

AU - Braasch, Fenja

AU - Koestner, Wolfgang

AU - Leiter, Edward H

AU - Seman, Michel

AU - Lund, Frances E

AU - Oppenheimer, Norman

AU - Haag, Friedrich

AU - Koch-Nolte, Friedrich

PY - 2005/3/15

Y1 - 2005/3/15

N2 - ADP-ribosyltransferase-2 (ART2), a GPI-anchored, toxin-related ADP-ribosylating ectoenzyme, is prominently expressed by murine T cells but not by B cells. Upon exposure of T cells to NAD, the substrate for ADP-ribosylation, ART2 catalyzes ADP-ribosylation of the P2X7 purinoceptor and other functionally important cell surface proteins. This in turn activates P2X7 and induces exposure of phosphatidylserine and shedding of CD62L. CD38, a potent ecto-NAD-glycohydrolase, is strongly expressed by most B cells but only weakly by T cells. Following incubation with NAD, CD38-deficient splenocytes exhibited lower NAD-glycohydrolase activity and stronger ADP-ribosylation of cell surface proteins than their wild-type counterparts. Depletion of CD38(high) cells from wild-type splenocytes resulted in stronger ADP-ribosylation on the remaining cells. Similarly, treatment of total splenocytes with the CD38 inhibitor nicotinamide 2'-deoxy-2'-fluoroarabinoside adenine dinucleotide increased the level of cell surface ADP-ribosylation. Furthermore, the majority of T cells isolated from CD38-deficient mice "spontaneously" exposed phosphatidylserine and lacked CD62L, most likely reflecting previous encounter with ecto-NAD. Our findings support the notion that ecto-NAD functions as a signaling molecule following its release from cells by lytic or nonlytic mechanisms. ART2 can sense and translate the local concentration of ecto-NAD into corresponding levels of ADP-ribosylated cell surface proteins, whereas CD38 controls the level of cell surface protein ADP-ribosylation by limiting the substrate availability for ART2.

AB - ADP-ribosyltransferase-2 (ART2), a GPI-anchored, toxin-related ADP-ribosylating ectoenzyme, is prominently expressed by murine T cells but not by B cells. Upon exposure of T cells to NAD, the substrate for ADP-ribosylation, ART2 catalyzes ADP-ribosylation of the P2X7 purinoceptor and other functionally important cell surface proteins. This in turn activates P2X7 and induces exposure of phosphatidylserine and shedding of CD62L. CD38, a potent ecto-NAD-glycohydrolase, is strongly expressed by most B cells but only weakly by T cells. Following incubation with NAD, CD38-deficient splenocytes exhibited lower NAD-glycohydrolase activity and stronger ADP-ribosylation of cell surface proteins than their wild-type counterparts. Depletion of CD38(high) cells from wild-type splenocytes resulted in stronger ADP-ribosylation on the remaining cells. Similarly, treatment of total splenocytes with the CD38 inhibitor nicotinamide 2'-deoxy-2'-fluoroarabinoside adenine dinucleotide increased the level of cell surface ADP-ribosylation. Furthermore, the majority of T cells isolated from CD38-deficient mice "spontaneously" exposed phosphatidylserine and lacked CD62L, most likely reflecting previous encounter with ecto-NAD. Our findings support the notion that ecto-NAD functions as a signaling molecule following its release from cells by lytic or nonlytic mechanisms. ART2 can sense and translate the local concentration of ecto-NAD into corresponding levels of ADP-ribosylated cell surface proteins, whereas CD38 controls the level of cell surface protein ADP-ribosylation by limiting the substrate availability for ART2.

KW - ADP Ribose Transferases

KW - ADP-ribosyl Cyclase

KW - Adenosine Diphosphate Ribose

KW - Animals

KW - Antigens, CD

KW - Antigens, CD38

KW - Immunomagnetic Separation

KW - In Vitro Techniques

KW - L-Selectin

KW - Membrane Glycoproteins

KW - Membrane Proteins

KW - Mice

KW - Mice, Inbred BALB C

KW - Mice, Inbred C57BL

KW - Mice, Knockout

KW - NAD

KW - Phosphatidylserines

KW - T-Lymphocytes

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

KW - Research Support, U.S. Gov't, P.H.S.

M3 - SCORING: Journal article

C2 - 15749861

VL - 174

SP - 3298

EP - 3305

JO - J IMMUNOL

JF - J IMMUNOL

SN - 0022-1767

IS - 6

ER -